Serum Interleukin-6, Interleukin-17A, and transforming growth factor beta are raised in systemic sclerosis with interstitial lung disease
Background: Dysregulation in cytokines like interleukin-6 (IL-6), interleukin-17A (IL-17A) and transforming growth factor-beta (TGF β1) has been pathogenically implicated in systemic sclerosis (SSc). The present study aimed to assess their serum levels in patients with SSc and correlate with clinica...
Main Authors: | Anupam Wakhlu, Rasmi Ranjan Sahoo, Jyoti Ranjan Parida, Mohit K Rai, Durga P Misra, Vinita Agrawal, Vikas Agarwal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=2;spage=107;epage=112;aulast=Wakhlu |
Similar Items
-
Interleukin – 17 and interleukin-10 as inflammatory and prevention biomarkers in periimplant diseases
by: Shirin Zahra Farhad, et al.
Published: (2019-01-01) -
Effects of curcumin on structure and the expression of interleukin-23 and interleukin-17 in rat retinal ischemia-reperfusion injury
by: Hai-Jiang Zhang, et al.
Published: (2017-08-01) -
The comparison of the salivary concentration of interleukin-17 and interleukin-18 in patients with chronic periodontitis and healthy individuals
by: Surena Vahabi, et al.
Published: (2020-01-01) -
Expression and significance of interleukin-17 and interleukin-22 in the serum and the lower esophageal sphincter of patients with achalasia
by: Zeyu Wang, et al.
Published: (2018-01-01) -
Interleukin-25 Produced by Synoviocytes Has Anti-inflammatory Effects by Acting As a Receptor Antagonist for Interleukin-17A Function
by: Fabien Lavocat, et al.
Published: (2017-05-01)